SKShabnam Khakpour-Ziaei

Shabnam Khakpour-Ziaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shabnam Khakpour-Ziaei has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    EVALUATION OF CHEMICAL COMPOSITION AND ANTIBACTERIAL ACTIVITY OF METHANOLIC EXTRACTS FROM NINE MEDICINAL PLANTS AGAINST STANDARD BACTERIAL STRAINS IN VITRO

    by Tayseer Ali Talab, Abolfazl Jafari Sales, Safa Meskini-Marandi, Shabnam Khakpour-Ziaei, Mehrdad Pashazadeh, Ali Esmail Al-Snafi, Mahdi Murshd Thuwaini

    This research aims to identify the antibacterial properties of medicinal plants, which are crucial in traditional medicine due to their natural origin and high safety. Nine medicinal plants from East Azerbaijan Province were gathered for experimental-laboratory investigation, with essential oils extracted and gas chromatography-mass spectrometry analysis used to identify active components. Additionally, methanolic extracts were prepared at different concentrations using the Soxhlet method, and their effects on bacteria were evaluated through the agar well diffusion method, as well as MIC and MBC tests. At 400 mg mL-1, all plant extracts in this investigation exhibited the strongest antibacterial activity. When it came to Gram-positive bacteria like Staphylococcus aureus and Bacillus cereus, the antibacterial activity of all plant extracts was noticeably greater than that of Gram-negative bacteria like Pseudomonas aeruginosa and Escherichia coli. The extracts of Glycyrrhiza glabra, Mentha piperita L., Rosa damascena, and Peganum harmala showed the strongest effects against Gram-positive bacteria, according to an evaluation of MIC and MBC values. The findings show that all plant methanolic extracts exhibit strong antibacterial properties against Gram-positive bacteria and may be viable therapeutic options. Furthermore, the essential oils of the plants under study included 209 different chemicals. Keywords: medicinal plants; antibacterial activity; pathogenic bacteria; Gram-positive bacteria; Gram-negative bacteria.


  • Open Access

    The hidden yet threatening link between hepatitis B virus and hepatocellular carcinoma: A Narrative Review

    by Abolfazl Jafari-Sales, Safa Meskini-Marandi, Shabnam Khakpour-Ziaei, Sadra Valipour, Mehrdad Pashazadeh

    Background: Hepatocellular carcinoma (HCC) is a highly aggressive liver cancer (LC), primarily driven by chronic hepatitis B virus (HBV) infection. Persistent HBV infection causes liver inflammation, dysfunction, and ultimately HCC through mechanisms like viral integration, oncogenic protein expression, and immune disruption. This study explores HBV-related HCC mechanisms and evaluates preventive/therapeutic approaches to ...

  • Open Access

    Impact of hepatitis B and C virus on chronic spontaneous urticaria; potential pathogenic triggers and aggravating factors

    by Abolfazl Jafari-Sales, Shabnam Khakpour-Ziaei, Safa Meskini-Marandi, Mehrdad Pashazadeh

    Chronic urticaria (CU) is a common dermatological condition characterized by persistent wheals lasting more than six weeks. Chronic spontaneous urticaria (CSU), the most prevalent CU subtype, significantly impairs patients' quality of life. Although its precise pathogenesis remains unclear, current evidence implicates multiple factors including immune dysregulation, stress, certain medications, and viral infections in its development and exacerbation. Among infectious triggers, hepatitis B (HBV) and C (HCV) viruses have emerged as potential CSU inducers. These viruses may trigger urticarial symptoms through various mechanisms, particularly immune system activation and cutaneous inflammatory responses. While the exact pathogenic pathways require further elucidation, clinical evidence suggests antiviral therapy may occasionally improve urticarial symptoms. Standard management of virus-associated CSU involves second-generation antihistamines as first-line treatment. For refractory cases, targeted therapies like omalizumab may be considered. Notably, successful HCV eradication has in some cases led to significant CSU improvement, an effect less frequently observed with HBV treatment. This study investigates the association between hepatitis infections and CSU, focusing particularly on elucidating how HBV and HCV could contribute to CSU pathogenesis.